Share on facebook
Share on twitter
Share on pinterest
Share on linkedin
Share on email

SHARE

Share on facebook
Share on twitter
Share on pinterest
Share on linkedin
Share on email

SHARE

MEND Welcomes New Investors

Backswing Ventures Joined by Numerous Physicians in Series Seed Round

December 27th, 2020 New York, NY – MEND has announced that it has completed an oversubscribed initial close of Series Seed round led by Backswing Ventures. The round was joined by more than a dozen surgeons and healthcare professionals. 

The New York City based life sciences company is focused on developing clinical applications of nutrition to enhance healing and patient outcomes as well as to improve health for the 100+ million US persons with acute illnesses and chronic conditions. In a global clinical nutrition market that is estimated at more than $50B, the company’s products stand out for science and quality and are being utilized by top hospital systems, leading private practices, the US Special Forces and by numerous professional sports teams.

“We continue to research and develop novel solutions for clinical and medical applications of natural compounds and functional foods, bringing evidence-based solutions to market with a new level of scientific rigor” says CEO Eziah Syed. “With this new capital and new revenue coming online from hospital contracts, we will be able to accelerate our research on new solutions and execute our first commercialization push with sustained marketing.”

“We have followed MEND very closely and are impressed with how they are building the business with an emphasis on clinical applications, science and research in nutrition and foods” says Backswing Managing Partner Kyle Asman, “they have carved out a focused position in a growing market that will only become more and more important.”

MUST SEE PANEL!

MONDAY MARCH 1 - 8PM EST / 5PM PST

Webinar: Enhancing orthopedic outcomes with clinical nutrition